<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00507806</url>
  </required_header>
  <id_info>
    <org_study_id>MRX-815-401</org_study_id>
    <nct_id>NCT00507806</nct_id>
  </id_info>
  <brief_title>Microbubble-Enhanced Clotbust Treatment of Acute Ischemic Stroke</brief_title>
  <official_title>Microbubble-Enhanced Clotbust Treatment of Acute Ischemic Stroke</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>ImaRx Therapeutics</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>ImaRx Therapeutics</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study is designed to examine the safety, tolerability, and activity of a combination of
      microbubbles (perflutren lipid microsphere [Definity®]) and continuous monitoring with 2 MHz
      transcranial Doppler ultrasound (TCD) as an adjunctive therapy to tissue plasminogen
      activator (tPA) treatment in subjects with acute ischemic stroke.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    for administrative reasons
  </why_stopped>
  <start_date>March 2005</start_date>
  <completion_date type="Actual">May 2006</completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of symptomatic intracranial hemorrhage</measure>
    <time_frame>72 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Complete recanalization of the occluded artery (TIBI 4-5)</measure>
    <time_frame>End of treatment</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>NIHSS score of 0-2</measure>
    <time_frame>24 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Favorable outcome (modified Rankin Scale or NIHSS 0-1)</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <condition>Acute Ischemic Stroke</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>perflutren lipid microsphere</intervention_name>
    <other_name>Definity</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Measurable focal neurological deficit (National Institutes of Health Stroke Scale
             [NIHSS] score &gt; 4 points)

          -  tPA eligible

          -  Occlusion of the middle cerebral artery

        Exclusion Criteria:

          -  Right to left cardiac shunt

          -  Uncontrolled hypertension

          -  Absent temporal windows
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andrei Alexandrov, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The University of Texas Health Science Center, Houston</affiliation>
  </overall_official>
  <reference>
    <citation>Alexandrov AV, Molina CA, Grotta JC, Garami Z, Ford SR, Alvarez-Sabin J, Montaner J, Saqqur M, Demchuk AM, Moyé LA, Hill MD, Wojner AW; CLOTBUST Investigators. Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke. N Engl J Med. 2004 Nov 18;351(21):2170-8.</citation>
    <PMID>15548777</PMID>
  </reference>
  <verification_date>July 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 25, 2007</study_first_submitted>
  <study_first_submitted_qc>July 25, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 27, 2007</study_first_posted>
  <last_update_submitted>July 25, 2007</last_update_submitted>
  <last_update_submitted_qc>July 25, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 27, 2007</last_update_posted>
  <keyword>Acute Ischemic Stroke</keyword>
  <keyword>Microbubbles</keyword>
  <keyword>Transcranial Doppler ultrasound</keyword>
  <keyword>TIBI</keyword>
  <keyword>Symptomatic Intracranial Hemorrhage</keyword>
  <keyword>modified Rankin Scale</keyword>
  <keyword>Recanalization</keyword>
  <keyword>Perflutren</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Ischemia</mesh_term>
    <mesh_term>Cerebral Infarction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

